Shots:
Gilead has entered into a definitive agreement to acquire Tubulis, making it an ADC research organization within Gilead, with the Munich site serving as a hub for ADC innovation
As per the deal, Gilead will acquire Tubulis for $3.15B upfront & ~$1.85B in contingent milestone payments; closing is expected in Q2’26
Acquisition will expand…
Shots:
Welcome to the 2025 edition of Know Your Investor, highlighting top venture capital firms driving healthcare innovation
This edition features Deep Track Capital, a firm dedicated to investing in life sciences companies that are advancing innovations to improve public health
In 2024, Deep Track Capital invested approximately $4.35B across six funding rounds, adding 32…

